Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients

Masayoshi Tasaki, Paolo Milani, Andrea Foli, Laura Verga, Laura Obici, Marco Basset, Margherita Bozzola, Giovanni Ferraro, Mario Nuvolone, Patrizia Morbini, Gianluca Capello, Mitsuharu Ueda, Konen Obayashi, Marco Paulli, Yukio Ando, Giampaolo Merlini, Giovanni Palladini, Francesca Lavatelli

Blood (2019) 134 (3): 320–323.

https://doi.org/10.1182/blood.2019000420

Published: 2019

Journal Articles

A practical approach to the diagnosis of systemic amyloidoses

Carlos Fernández de Larrea, Laura Verga, Patrizia Morbini, Catherine Klersy, Francesca Lavatelli, Andrea Foli, Laura Obici, Paolo Milani, Gian Luca Capello, Marco Paulli, Giovanni Palladini, Giampaolo Merlini

Blood (2015) 125 (14): 2239–2244.

https://doi.org/10.1182/blood-2014-11-609883

Published: 2015

Journal Articles

Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue

Francesca Brambilla, Francesca Lavatelli, Dario Di Silvestre, Veronica Valentini, Rossana Rossi, Giovanni Palladini, Laura Obici, Laura Verga, Pierluigi Mauri, Giampaolo Merlini

Blood (2012) 119 (8): 1844–1847.

https://doi.org/10.1182/blood-2011-07-365510

Published: 2012

Includes: Supplemental data

Journal Articles

The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44

Vittorio Perfetti, Giovanni Palladini, Simona Casarini, Valentina Navazza, Paola Rognoni, Laura Obici, Rosangela Invernizzi, Stefano Perlini, Catherine Klersy, Giampaolo Merlini

Blood (2012) 119 (1): 144–150.

https://doi.org/10.1182/blood-2011-05-355784

Published: 2012

Journal Articles

Treatment of AL Amyloidosis with Bortezomib Combined with Alkylating Agents: Results From a Prospective Series of Unselected Patients,

Giovanni Palladini, MD, PhD, Paolo Milani, MD, Andrea Foli, MD, Paola Russo, MD, Francesca Lavatelli, MD, Laura Obici, MD, Giampaolo Merlini, MD

Blood (2011) 118 (21): 3977.

https://doi.org/10.1182/blood.V118.21.3977.3977

Published: 2011

Journal Articles

Salvage Therapy with Lenalidomide and Dexamethasone (LDex) In Patients with Advanced AL Amyloidosis Refractory to Both Melphalan and Bortezomib

Giovanni Palladini, MD, PhD, Paola Russo, MD, Paolo Milani, MD, Andrea Foli, MD, Letizia Zenone Bragotti, MD, Laura Obici, MD, Francesca Lavatelli, MD, Silvia Brugnatelli, MD, Vittorio Perfetti, MD, PhD, Rosangela Invernizzi, MD, Giampaolo Merlini, MD

Blood (2010) 116 (21): 3062.

https://doi.org/10.1182/blood.V116.21.3062.3062

Published: 2010

Journal Articles

The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis

Giovanni Palladini, Alessandra Barassi, Catherine Klersy, Rosana Pacciolla, Paolo Milani, Gabriele Sarais, Stefano Perlini, Riccardo Albertini, Paola Russo, Andrea Foli, Letizia Zenone Bragotti, Laura Obici, Remigio Moratti, Gian Vico Melzi d'Eril, Giampaolo Merlini

Blood (2010) 116 (18): 3426–3430.

https://doi.org/10.1182/blood-2010-05-286567

Published: 2010

Includes: Supplemental data

Journal Articles

High-Sensitivity Troponin Assay Improves the Detection of Cardiac Involvement in AL Amyloidosis and Is the Most Powerful Prognostic Determinant.

Giovanni Palladini, Alessandra Barassi, Gabriele Sarais, Ruggero Capra, Andrea Foli, Paola Russo, Riccardo Albertini, Letizia Zenone Bragotti, Laura Obici, Stefano Perlini, Remigio Moratti, Gian Vico Melzi D'Eril, Giampaolo Merlini

Blood (2009) 114 (22): 1782.

https://doi.org/10.1182/blood.V114.22.1782.1782

Published: 2009

Journal Articles

Treatment with Oral Melphalan and Dexamethasone of An Extended Patient Population with AL Amyloidosis.

Giovanni Palladini, Paola Russo, Andrea Foli, Letizia Zenone Bragotti, Francesca Lavatelli, Vittorio Perfetti, Laura Obici, Stefano Perlini, Giampaolo Merlini

Blood (2009) 114 (22): 3889.

https://doi.org/10.1182/blood.V114.22.3889.3889

Published: 2009

Journal Articles

A Phase II Trial of Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) in Previously Treated Patients with AL Amyloidosis.

Giovanni Palladini, Paola Russo, Letizia Zenone Bragotti, Andrea Foli, Francesco Musca, Francesca Lavatelli, Vittorio Perfetti, Laura Obici, Stefano Perlini, Giampaolo Merlini

Blood (2009) 114 (22): 2863.

https://doi.org/10.1182/blood.V114.22.2863.2863

Published: 2009

Journal Articles

Role of NT-ProBNP to Assess the Adequacy of Treatment Response in AL Amyloidosis.

Ashutosh Wechalekar, Giampaolo Merlini, Julian D Gillmore, P. Russo, Helen J Lachmann, Laura Obici, Philip N Hawkins, Giovanni Palladini

Blood (2008) 112 (11): 1689.

https://doi.org/10.1182/blood.V112.11.1689.1689

Published: 2008

Journal Articles

Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis

Giovanni Palladini, Paola Russo, Mario Nuvolone, Francesca Lavatelli, Vittorio Perfetti, Laura Obici, Giampaolo Merlini

Blood (2007) 110 (2): 787–788.

https://doi.org/10.1182/blood-2007-02-076034

Published: 2007

Journal Articles

Early Harvest Followed by Melphalan-Dexamethasone and Second-Line Autologous Stem Cell Transplantation in AL Amyloidosis.

Giovanni Palladini, MD, Vittorio Perfetti, MD, Paola Russo, MD, Francesca Lavatelli, MD, Mario Nuvolone, MD, Laura Obici, MD, Giampaolo Merlini, MD

Blood (2006) 108 (11): 5449.

https://doi.org/10.1182/blood.V108.11.5449.5449

Published: 2006

Journal Articles

Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL

Giovanni Palladini, Francesca Lavatelli, Paola Russo, Stefano Perlini, Vittorio Perfetti, Tiziana Bosoni, Laura Obici, Arthur R. Bradwell, GianVico Melzi D'Eril, Roberto Fogari, Remigio Moratti, Giampaolo Merlini

Blood (2006) 107 (10): 3854–3858.

https://doi.org/10.1182/blood-2005-11-4385

Published: 2006

Journal Articles

The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL)

Giovanni Palladini, Vittorio Perfetti, Stefano Perlini, Laura Obici, Francesca Lavatelli, Riccardo Caccialanza, Rosangela Invernizzi, Benedetto Comotti, Giampaolo Merlini

Blood (2005) 105 (7): 2949–2951.

https://doi.org/10.1182/blood-2004-08-3231

Published: 2005

Journal Articles

Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation

Giovanni Palladini, Vittorio Perfetti, Laura Obici, Riccardo Caccialanza, Alessandra Semino, Fausto Adami, Giobatta Cavallero, Roberto Rustichelli, Giovambattista Virga, Giampaolo Merlini

Blood (2004) 103 (8): 2936–2938.

https://doi.org/10.1182/blood-2003-08-2788

Published: 2004

Journal Articles

Treatment of AL Amyloidosis with 4′-Iodo-4′-Deoxydoxorubicin: An Update

Giampaolo Merlini, Ernesto Anesi, Pietro Garini, Vittorio Perfetti, Laura Obici, Edoardo Ascari, Maria J. Lechuga, Giuseppe Capri, Luca Gianni

Blood (1999) 93 (3): 1112–1113.

https://doi.org/10.1182/blood.V93.3.1112

Published: 1999

Journal Articles

Evidence That Amyloidogenic Light Chains Undergo Antigen-Driven Selection

Vittorio Perfetti, Paola Ubbiali, Maurizio Colli Vignarelli, Marta Diegoli, Roberta Fasani, Monica Stoppini, Antonella Lisa, Palma Mangione, Laura Obici, Eloisa Arbustini, Giampaolo Merlini

Blood (1998) 91 (8): 2948–2954.

https://doi.org/10.1182/blood.V91.8.2948.2948_2948_2954

Published: 1998

NARROW

Simple, reliable detection of amyloid in fat aspirates using the fluorescent dye FSB: prospective study in 206 patients

A practical approach to the diagnosis of systemic amyloidoses

Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue

The repertoire of λ light chains causing predominant amyloid heart involvement and identification of a preferentially involved germline gene, IGLV1-44

Treatment of AL Amyloidosis with Bortezomib Combined with Alkylating Agents: Results From a Prospective Series of Unselected Patients,

Salvage Therapy with Lenalidomide and Dexamethasone (LDex) In Patients with Advanced AL Amyloidosis Refractory to Both Melphalan and Bortezomib

The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis

High-Sensitivity Troponin Assay Improves the Detection of Cardiac Involvement in AL Amyloidosis and Is the Most Powerful Prognostic Determinant.

Treatment with Oral Melphalan and Dexamethasone of An Extended Patient Population with AL Amyloidosis.

A Phase II Trial of Cyclophosphamide, Lenalidomide and Dexamethasone (CLD) in Previously Treated Patients with AL Amyloidosis.

Role of NT-ProBNP to Assess the Adequacy of Treatment Response in AL Amyloidosis.

Treatment with oral melphalan plus dexamethasone produces long-term remissions in AL amyloidosis

Early Harvest Followed by Melphalan-Dexamethasone and Second-Line Autologous Stem Cell Transplantation in AL Amyloidosis.

Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL

The combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL)

Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation

Treatment of AL Amyloidosis with 4′-Iodo-4′-Deoxydoxorubicin: An Update

Evidence That Amyloidogenic Light Chains Undergo Antigen-Driven Selection

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only